Literature DB >> 22307369

The role of bone microenvironment, vitamin D and calcium.

Daniele Santini1, Francesco Pantano, Bruno Vincenzi, Giuseppe Tonini, Francesco Bertoldo.   

Abstract

Starting first from Paget's "seed and soil" to the latest hypothesis about metastatic process involving the concept of a premetastatic niche, a large amount of data suggested the idea that metastatization is a multistep coordinated process with a high degree of efficiency. A specific subpopulation of cells with tumor-initiating and migratory capacity can selectively migrate toward sites that are able to promote survival, and/or proliferation of metastatic tumor cells through a microenvironment modification. Bone plays a pivotal role in this process, acting not only as a preferential site for cancer cells' homing and proliferation, due to a complex interplay between different cellular phenotypes such as osteoblasts and osteoclasts, but also as a source of bone marrow precursors that are able to facilitate the metastatic process in extra-skeletal disease. Moreover, bone microenvironment has the unique capacity to retain cancer stem cells in a quiescent status, acting as a reservoir that is able to cause a metastatic spread also many years after the resection of the primary tumor. To add a further level of complexity, these mechanisms are strictly regulated through the signalling through several soluble factors including PTH, vitamin D or calcium concentration. Understanding this complexity represents a major challenge in anti-cancer research and a mandatory step towards the development of new drugs potentially able not only to reduce the consequences of bone lesions but also to target the metastatization process from the "bone pre-neoplastic niche" to "visceral pre-neoplastic niches".

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22307369     DOI: 10.1007/978-3-642-21892-7_2

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  5 in total

1.  Mineral metabolism abnormalities in patients with prostate cancer: a systematic case controlled study.

Authors:  Francesco Minisola; Cristiana Cipriani; Luciano Colangelo; Mirella Cilli; Alessandro Sciarra; Magnus Von Heland; Luciano Nieddu; Emanuela Anastasi; Roberto Pascone; Valeria Fassino; Daniele Diacinti; Flavia Longo; Salvatore Minisola; Jessica Pepe
Journal:  Endocrine       Date:  2017-06-28       Impact factor: 3.633

2.  Metastatic sites as predictors in advanced NSCLC treated with PD-1 inhibitors: a systematic review and meta-analysis.

Authors:  Yangyun Huang; Lihuan Zhu; Tianxing Guo; Wenshu Chen; Zhenlong Zhang; Wujin Li; Xiaojie Pan
Journal:  Hum Vaccin Immunother       Date:  2020-10-20       Impact factor: 3.452

3.  RANK/RANKL pathway in cancer: Biological activity beyond bone?

Authors:  Francesco Pantano; Philippe Clézardin; Daniele Santini
Journal:  J Bone Oncol       Date:  2012-11-29       Impact factor: 4.072

4.  A single administration of combination therapy inhibits breast tumour progression in bone and modifies both osteoblasts and osteoclasts.

Authors:  H K Brown; P D Ottewell; C A Evans; R E Coleman; I Holen
Journal:  J Bone Oncol       Date:  2012-06-19       Impact factor: 4.072

5.  Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO).

Authors:  Luisella Cianferotti; Francesco Bertoldo; Heike A Bischoff-Ferrari; Olivier Bruyere; Cyrus Cooper; Maurizio Cutolo; John A Kanis; Jean-Marc Kaufman; Jean-Yves Reginster; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2017-04-07       Impact factor: 3.633

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.